(Updated - July 27, 2026 11:02 AM EDT)

B.Riley analyst Madison El-Saadi downgraded Capricor Therapeutics (NASDAQ: CAPR) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE